Sorrento Announces FDA Authorization to Proceed With Phase 2 Study of Abivertinib (Fujovee™) to Treat Metastatic Castrate Resistant Prostate Cancer (MAVERICK Trial)

3 years ago

FDA granted IND clearance for Abivertinib (Fujovee™) for the Phase 2 MAVERICK study to be conducted in participants with metastatic…

Icario/Harris Poll Survey Uncovers Challenges Associated with Educating Medicaid Members on Redetermination and Re-enrollment

3 years ago

Findings Reaffirm Significant Disparities Between Higher-and Lower-Income Members, While Only 56% of Members Report Receiving Helpful Info About Medicaid Redetermination…

Virax Biolabs Introduces New Board of Directors, Announces Members

3 years ago

London, United Kingdom, May 17, 2022 (GLOBE NEWSWIRE) -- Virax Biolabs Introduces New Board of Directors, Announces Members London, United…

New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Therapy

3 years ago

Published in Brain Stimulation Journal, study describes insights from world’s largest depression registry MALVERN, Pa., May 17, 2022 (GLOBE NEWSWIRE)…

Veru to Present at the H.C. Wainwright Global Investment Conference on May 24th 2022

3 years ago

MIAMI, May 17, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for…

Trusting Heart Blood Center’s Documentary, “The Platelet Problem,” is Recognized in the Top Ten at the 26th Annual Webby Awards

3 years ago

Webby Award Trusting Heart Blood Center’s Webby Award for their microdocumentary, ‘The Platelet Problem,’ placing in the top 10 Best…

Assure to Attend Investor Conferences in May and June 2022

3 years ago

DENVER, May 17, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative…

Reviva Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

3 years ago

CUPERTINO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage…

BioCorRx Business Update for the First Quarter of 2022

3 years ago

ANAHEIM, CA, May 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire  – BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and…

WIMI Hologram Academy: Research on the boundary between Virtuality and Reality in the application scene based on VR technology

3 years ago

HONG KONG, May 17, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…